A New Audio Interview with Michael Llamas, President of Medical Marijuana, Inc., is now at SmallCapVoice.com

AUSTIN, Texas, May 22, 2012 /PRNewswire/ — SmallCapVoice.com, Inc. announced today that a new audio interview with Medical Marijuana, Inc. (PINKSHEETS: MJNA) is now available. The interview can be heard at http://smallcapvoice.com/blog/5-21-12-smallcapvoice-interview-with-medical-marijuana-inc-pink-sheets-mjna.

Recent company activity and highlights:

The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012. This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.

Operational and development highlights

Operating highlights of the quarter were as follows:

• Acquired two additional Wellness Managed Services accounts which will generate estimated annual revenues of $1.7 million.
• Closed a $1.04 million upfront payment licensing transaction for high value hemp extracts.
• Retired 14,600,000 shares worth approximately $1.0 million dollars.
• Cannabank, the private equity group that finances and incubates early stage acquisitions for MJNA, has agreed to finance several key transactions for the company including the European based pharmaceutical firm previously announced.
• Secured $4 million in non-dilution, non-recourse finance for the acquisition and development of strategic acquisitions.

In addition, since the close of the first quarter, Medical Marijuana, Inc. has:

• Completed the acquisition of Dixie Elixirs & Edibles brand, intellectual property, proprietary formulas and extraction processes. In conjunction it formed Red Dice Holdings, as was announced in late April, to develop manufacturing and distribution partnerships for Dixie in every state and country that has legalized medical cannabis.
• Begun hemp-based extraction product development beyond the medical marijuana industry, crossing into the nationally legal category of health and wellness with such products as sleep aids, topical and pain management. A market launch of the new products is expected by the end of the second quarter.
• Brought PhytoSPHERE systems on-line and will begin to market the benefits of its seed-to-sale product growth and cultivation technology in an attempt to secure licensing agreements worldwide.

Additional operational updates for 2012

• The Company has built additional raw ingredients supply sources on four continents in preparation for international expansion and it continues to develop international sales and distribution channels for its high-value extracts and compounds and related products produced by Dixie Elixirs and Edibles.
• Medical Marijuana, Inc.’s Wellness Managed Services (WMS) division plans to expand internationally to provide additional clinics, doctor’s offices and wellness centers under the WMS umbrella.
• PhytoSPHERE plans to develop and launch a national/international marketing campaign in the third quarter to support sales of licensing agreements for its proprietary indoor planting, cultivation and extraction technology.
• Medical Marijuana, Inc. plans to establish a "Raw Ingredients Division" by the third quarter to provide raw ingredients and production services to other cannabis-based businesses.
• MJNA to begin regular Investor Conference Calls announcing quarterly results and/or upon significant corporate developments beginning with its second quarter results (date is currently TBD).
• MJNA established a corporate website and launched a rebranding effort for added market and shareholder awareness.
• The Company is aggressively pursuing the acquisition and filing of additional product patents.
• MJNA Filed an updated 15-C-211

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
Skype: SmallCapVoice.com
AIM: SmallCapVoice7

SOURCE SmallCapVoice.com

DENVER, May 17, 2012 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), has commenced the first step in the process for its 15c2-11 filing status with BMA Securities located in 608 Silver Spur Road, Suite 100, Rolling Hills Estates, CA 90274. The filing of a 15c2-11 is designed to allow non-reporting public company’s securities to be quoted on the National Association of Securities Dealers’ (“NASD”) Over-the-Counter Bulletin Board (“OTCBB”) by filing required disclosures. Once approved, this filing status causes another level of transparency which will be attractive to additional market makers and brokerage firms, thereby providing increased visibility to a broader set of investors.

“This is a significant step in the growth and development of Medical Marijuana, Inc.,” said Michael Llamas, President of Medical Marijuana, Inc. “As we continue to mature as a company, it is critical to our growth path that we can access new and additional capital markets and investors who understand the value that a company like ours can create. This filing, and the subsequent approval will allow us to educate a much broader market about the shareholder value we are building through our comprehensive set of portfolio companies focused on this explosive growth industry.”

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Corporate Contact:

Medical Marijuana, Inc.

Toll Free: 888-OTC-MJNA (888-682-6562)

www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.com, Inc.
P. 512-267-2430
F. 512-267-2530
Skype: SmallCapVoice.com
AIM: SmallCapVoice7

SEATTLE, May 16, 2012 (GLOBE NEWSWIRE) — Plandai Biotechnology, Inc. (OTCBB:PLPL), a producer of highly bioavailable botanical extracts, today announced a preliminary agreement with ZZ2, a private farming conglomerate in Southern Africa and the largest producer of fresh tomatoes in the continent of Africa. Based on a long-standing working relationship, Dunn Roman Holdings Africa (Pty) Limited, a subsidiary of Plandai, will, under a new contract, acquire tomato waste from ZZ2 which will be processed to recover highly bioavailable antioxidants using the company’s exclusive Hydrodynamic Extraction System.

Plandai Chairman and Chief Executive Officer, Roger Duffield, commented, “As with green tea catechin extract, our hydrodynamic system converts the tomato carotenoid isomers into a highly bioavailable product. This partnership with ZZ2 is especially advantageous because it gives us an extremely inexpensive and readily available source material throughout the year. With an initial agreement to acquire 30 tons of tomato waste per day, we can yield substantial volumes of carotenoids (lycopene, phytoene and phytofluene). With the current market price for even poorly-absorbed lycopene at $3,000/kg, this opportunity could add in excess of $700,000 in monthly revenues.

Discussing the timing of commencing production of these carotenoids, Mr. Duffield added, “A huge portion of our prior research has been in this field and has already been validated through a USDA study. As shown in the recent publication by Dr. Ishida in Food Chemistry—Effects of a Hydrodynamic Process on Extraction of Carotenoids from Tomato—Plandai’s extraction process has already demonstrated the ability to deliver highly bioavailable carotenoids in numerous studies undertaken in conjunction with the California tomato processing industry and the USDA. In addition, unlike our green tea catechin extract, there will be no delay in getting raw materials ready for extraction. ZZ2 has an ample and ready supply of tomato waste available 365 days a year. We therefore anticipate that the tomato carotenoid extracts could actually come to market well ahead of our green tea gallate extract and bring us one step closer to becoming the world’s largest supplier of highly bioavailable botanical extracts from live plant materials.”

For additional information on ZZ2, visit www.zz2.biz. A memorandum of Understanding is under review by the respective attorneys and is expected to executed shortly.
“Effects of a hydrodynamic process on extraction of carotenoids from tomato”
Betty K. Ishida, Mary H. Chapman, United States Department of Agriculture,
Food Chemistry 132 (2012) 1156–1160

About Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. Its principle holdings consist of land, farms and infrastructure in South Africa. Web site: http://www.plandaibiotech.com/

Safe Harbor Statement

The information provided may contain forward-looking statements and involve risks and uncertainties. Results, events and performances could vary from those contemplated. These statements involve risks and uncertainties which may cause actual results, expressed or implied, to differ from predicted outcomes. Risks and uncertainties include product demand, market competition, and Plandai’s ability to meet current or future plans. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Plandai is not obliged to publicly release revisions to any forward-looking statement, to reflect events or circumstances afterward, or to disclose unanticipated occurrences, except as required under applicable laws.

CONTACT: Tel: (425) 466-0212
Email: info@Plandaibiotech.com

Company Sees 400 Plus Percent Quarter-over-Quarter and an Accumulative 12,000 Plus Percent Year-over-Year Revenue Growth Fueled by Licensing Agreements and Acquisitions

SAN DIEGO, May 15, 2012 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), one of the medical marijuana (MMJ) industry’s premier cannabis and hemp industry innovators, today announced its first quarter earnings. The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012. This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.

Operational and development highlights

Operating highlights of the quarter were as follows:

• Acquired two additional Wellness Managed Services accounts which will generate estimated annual revenues of $1.7 million.
• Closed a $1.04 million upfront payment licensing transaction for high value hemp extracts.
• Retired 14,600,000 shares worth approximately $1.0 million dollars.
• Cannabank, the private equity group that finances and incubates early stage acquisitions for MJNA, has agreed to finance several key transactions for the company including the European based pharmaceutical firm previously announced.
• Secured $4 million in non-dilution, non-recourse finance for the acquisition and development of strategic acquisitions.

In addition, since the close of the first quarter, Medical Marijuana, Inc. has:

• Completed the acquisition of Dixie Elixirs & Edibles brand, intellectual property, proprietary formulas and extraction processes. In conjunction it formed Red Dice Holdings, as was announced in late April, to develop manufacturing and distribution partnerships for Dixie in every state and country that has legalized medical cannabis.
• Begun hemp-based extraction product development beyond the medical marijuana industry, crossing into the nationally legal category of health and wellness with such products as sleep aids, topical and pain management. A market launch of the new products is expected by the end of the second quarter.
• Brought PhytoSPHERE systems on-line and will begin to market the benefits of its seed-to-sale product growth and cultivation technology in an attempt to secure licensing agreements worldwide.

Comments regarding operations and outlook

“The first quarter of 2012 brought into clear focus all that we have been working towards since Cannabank’s initial investment into Medical Marijuana, Inc. about a year ago,” said Michael Llamas, President of Medical Marijuana, Inc. “We have spent this last year essentially getting our house in order by clarifying the growth strategy and systematically identifying, acquiring and growing early stage companies across the spectrum of the MMJ industry from product development to retail sales. As witnessed by our strong quarter-over-quarter and year-over-year growth, there is tremendous opportunity in this industry. We have the capital and the systems in place to buy, incubate and grow the best companies across multiple categories within the industry. At the same time, there is aggressive natural attrition of other companies and whole categories as the industry right sizes itself-which creates further opportunities and differentiation for Medical Marijuana, Inc. this truly is the perfect storm for acquiring income producing businesses.

“However, we also know that a 12,000 percent year-over-year growth is decidedly a factor of where we are in our growth cycle. We won’t always have such favorable comparables moving forward past our second year. We do expect the comparable growth to normalize, but more importantly, we expect continued healthy growth in our core businesses as they begin to mature and the industry stabilizes. I’m equally proud that we have been able to maintain this rapid growth with a small core of dedicated and truly innovative employees and as a result, our operating costs have begun to stabilize since the close of the fourth quarter. We anticipate continued cost efficiency in line with future growth.”

Additional operational updates for 2012

• The Company has built additional raw ingredients supply sources on four continents in preparation for international expansion and it continues to develop international sales and distribution channels for its high-value extracts and compounds and related products produced by Dixie Elixirs and Edibles.
• Medical Marijuana, Inc.’s Wellness Managed Services (WMS) division plans to expand internationally to provide additional clinics, doctor’s offices and wellness centers under the WMS umbrella.
• PhytoSPHERE plans to develop and launch a national/international marketing campaign in the third quarter to support sales of licensing agreements for its proprietary indoor planting, cultivation and extraction technology.
• Medical Marijuana, Inc. plans to establish a “Raw Ingredients Division” by the third quarter to provide raw ingredients and production services to other cannabis-based businesses.
• MJNA to begin regular Investor Conference Calls announcing quarterly results and/or upon significant corporate developments beginning with its second quarter results (date is currently TBD).
• MJNA established a corporate website and launched a rebranding effort for added market and shareholder awareness.
• The Company is aggressively pursuing the acquisition and filing of additional product patents.

“With 16 states and Washington, D.C. allowing for legal use of medical marijuana and twelve more states with legalization initiatives on the ballot, we are confident that the opportunity for continued growth in the US, regardless of state boundaries, is exceptional,” added Llamas. “Equally as important is the growing movement towards decriminalization outside the US and across Europe, which will allow us to leverage what we have learned in mature legalized states like Colorado and California, and apply it to international markets. We see opportunity for significant national and international expansion by the end of 2012 and we are currently putting in place the necessary supply chain and infrastructure elements to best position Medical Marijuana, Inc. and our shareholders to benefit from this growth.”

Financial Tables

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.

Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
Skype: SmallCapVoice.com
AIM: SmallCapVoice7

SOURCE Medical Marijuana, Inc.

SALT LAKE CITY, UT–(Marketwire -05/15/12)- Green Endeavors, Inc. (GRNE), a majority owned subsidiary of Nexia Holdings, Inc. (NXHD), announced continued revenue growth in the month of April.

Green Endeavors is reporting that the combined unaudited revenues for both Landis Lifestyle Salon locations were $246,167 for the month of April 2012; which is an increase of $16,793 or 7.3% compared to April 2011. The newer Marmalade salon reported April 2012 sales of $71,966; a $5,646 or 8.5% increase from the comparable month of 2011. Our flagship Liberty Heights salon reported revenues in April 2012 of $174,201; an $11,417 or 6.8% increase over April 2011.

Richard D. Surber, CEO of GRNE, stated, “Management reviewed hundreds of resumes in April in our continued quest to find the best talent for our operations. We are in the process of hiring several stylists, guest relations staff, and assistant managers. We have also begun training staff for the Aveda™ Experience Center. I expect that our efforts will result in continued growth.”

About Green Endeavors, Inc.:

Green Endeavors, Inc. (GRNE) headquartered in Salt Lake City, Utah, is a holding company with operations in health & beauty. GRNE’s wholly owned subsidiaries, Landis Salons, Inc. and Landis Salons II, Inc. http://www.landissalons.com, operate hair salons built around the world-class AVEDA™ product line. For more information, visit http://www.green-endeavors.com. The numbers are not audited and have not been reviewed by an independent accountant. GRNE strongly encourages the public to read the above information in conjunction with its filings and disclosures filed in 2011 and 2012. GRNE’s disclosures can be viewed at www.sec.gov and www.otcmarkets.com. Investors should not invest more than they can afford to lose in penny stocks.

Contact:
FOR MORE INFORMATION, CONTACT:
Richard Surber
President
Green Endeavors, Inc.
801-575-8073 x 106
Email Contact

ATLANTA, May 14, 2012 (GLOBE NEWSWIRE) — OTC Stock Review announces that it has initiated coverage of Medical Marijuana Inc. (OTC:MJNA), which is the first publicly held company vested in the medical marijuana and industrial hemp markets. MJNA is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.

Not only is it legal, MJNA is an environmentally friendly and economically sustainable business. Since new management, MJNA has seen an explosion in revenue, up nearly 4,000%. MJNA does not grow, or sell marijuana, but, in fact, owns patented and proprietary methods for governments, municipalities to implement production, tracking, packaging and integration of pharmaceutical grade medical herbs. Over the past few years research has shown many new benefits arising from medical marijuana, which has served to spark the upsurge in the number of US States approving the medicinal usage and a similar upsurge in the number of doctors willing to write prescriptions. In our report, we have outlined several reasons we believe this trend should continue.

The complete report is available at http://www.otcstockreview.com/MJNA_review.pdf. You can also visit Medical Marijuana Inc.’s web site at http://www.medicalmarijuanainc.com.

OTC Stock Review provides investors with information on companies with less than $250 million in market capitalization. Members receive regular emails of stock opinions and market coverage, including both global and domestic. Please visit http://www.otcstockreview.com.

NOTE: The purpose of this release is to introduce the reader to OTCStockReview.com and Medical Marijuana Inc. OTC Stock Review is not a Registered Investment Advisor or a Broker/Dealer. Information and opinions presented in this release are solely for informative purposes and not intended as investment advice. This document contains information obtained from public sources about Medical Marijuana Inc., but does not contain all the relevant material information necessary to evaluate the company. This release is not to be considered an offer to buy, sell, hold, and/or otherwise trade in the securities of Medical Marijuana Inc., as profiled. OTC Stock Review has been compensated five thousand dollars to perform investor relations services for Medical Marijuana Inc. Officers, directors, and employees of OTC Stock Review, may hold a long equity position of a profiled Company and may trade in these securities for their own accounts. Carefully review profiled companies with your investment advisor, stockbroker, or other such professional. OTC Stock Review is not liable for any investment decisions by its readers or their advisors. Any analysis contained herein does not purport to be a complete analysis of the profiled companies. Readers are encouraged to obtain copies of the profiled Company’s periodic reports filed with United States Securities and Exchange Commission, which are generally available at http://www.sec.gov. You can view our complete disclaimer at http://www.otcstockreview.com/disclaimer.htm

Contact:

OTC Stock Review
David Kugelman
dk@otcstockreview.com

AUSTIN, Texas, May 15, 2012 /PRNewswire/ — SmallCapVoice.com, Inc. announced today that a new audio interview with Sharewell Capital Group, Inc. (Pink Sheets: SHCG) is now available. The interview can be heard at http://smallcapvoice.com/blog/5-11-12-smallcapvoice-interview-with-sharewell-capital-group-pink-sheets-shcg

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About Sharewell Capital Group, Inc.

Sharewell Capital Group, Inc. (“Sharewell”) is a publicly-traded holding company focused on acquiring controlling interests and making strategic investments in undervalued assets with significant growth potential. Sharewell is headquartered in San Diego, California, and is publicly-traded under the symbol SHCG. Sharewell was organized in December of 2010, and is embarking on an aggressive business plan to raise permanent capital, conduct extensive diligence and sign letters of intent with initial target acquisitions, in order to build a portfolio of companies and assets with the potential to create significant shareholder equity over time. Our aim is to maximize the growth and profitability of our portfolio companies and strategic investments, and hold or exit as deemed prudent for our shareholders.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company’s control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission.

SHCG Contact:
info@sharewellcapital.com
Contact for SmallCapVoice.com
Stuart T. Smith
512-267-2430
info@smallcapvoice.com

SOURCE SmallCapVoice.com, Inc.

Source: PR Newswire (May 15, 2012 – 8:00 AM EDT)

Colorado’s Leading Manufacturer of Edible Medical Marijuana Products Looks to Ensure Global Product Consistency and Enhanced Cost Control with PhytoSPHERE’s Systems

DENVER, May 10, 2012 /PRNewswire/ — Dixie Elixirs & Edibles (Dixie), Colorado’s premier Medical Marijuana infused products company, today announced that it has entered into an agreement with fellow Medical Marijuana, Inc. (OTC: MJNA) portfolio company, PhytoSPHERE, to purchase the rights to PhytoSPHERE’s proprietary indoor planting, cultivation and extraction technology. While Dixie currently operates only in Colorado, this agreement will make Dixie one of the first medical marijuana infused product manufacturers in the world to own end-to-end production of its products. In addition, this technology will be made available to all licensees of Dixie’s intellectual property as outlined in the recent announcement of the formation of Red Dice Holdings, LLC which was formed to legally license the Dixie brand and propriety product development process beyond its current Colorado borders.

PhytoSPHERE’s highly efficient growth, packaging and extraction technologies will provide Dixie a compact, safe, pollutant-free facility which will allow it to:

• Greatly increase plant production through yields that significantly exceed traditional methods
• Completely control the cultivation environment resulting in superior plant growth, uniform strain purity, quality crop production, and year-round production potential
• Reduce per-unit costs compared to traditional methods by eliminating the use of pesticides, fungicides and herbicides
• Produce Pharmaceutical grade extracts
• Establish antibacterial environments and packaging systems
• Control post production processing with proprietary standardization methods

PhytoSPHERE’s three core technologies consist of:

• A module that places rows of plants perpendicular to an interior light source, which helps accelerate the growth rate and efficiency of the particular plant that is being cultivated. Computer operated sprayers ensure even distribution of nutrient feeding solutions to the crops resulting in an abundance of plants with strong, compact, and multi-directional growth. This state-of-the-art technology is fully contained, meaning crops can be grown year-round in any location using precise combinations of light, water, and nutrients to maximize production.
• A proprietary antibacterial product clipping, curing and packaging system, allowing for a truly pharmaceutical grade method of cultivation.
• An extraction and production process for cannabinoid based compounds derived from the cannabis plant, which uses standardized processes and technology to create the world’s leading pharmaceutical grade extracts.

“Currently 80 percent of all medical cannabis and hemp is grown outdoors, but at PhytoSPHERE we know that while this method is still dominant, it is also highly inefficient with lower yields than indoor cultivation and does not allow for a true pharmaceutical grade cannabis based product,” said Michael Llamas, President of Medical Marijuana Inc. “With outdoor cultivation you cannot ensure the quality, consistency or potency of the product nor can you establish a contaminant free environment. Dixie is clearly a thought leader in the area of alternative medical marijuana delivery systems and when partnered with our software driven, indoor growing and extraction technologies, there is a tremendous opportunity to increase production, stabilize consistency and offer patients the very best quality medicine available.”

“As we continue to grow our operations, serving more patients across Colorado and adding new dispensaries daily, we have recognized the need for greater cost-control and 100 percent consistency across Dixie’s products,” said Tripp Keber, President and CEO of Dixie Elixirs and Red Dice Holdings, LLC. “However, cost control and consistency are arguably very challenging given the various environmental factors that can affect the key ingredient in our products. In fact, the only way to ensure that each and every plant grown meets our rigorous standards and matches the cannabinoid profile we desire for Dixie products is to manage the growth and cultivation process from seed to sale in a very controlled environment. We are lucky enough to have a true innovator and leader in that end-to-end solution development, PhytoSPHERE, as a sister company in the Medical Marijuana, Inc. portfolio. The execution of this licensing agreement is a true game-changer and puts us in the unique and enviable position of being able to cost-effectively cultivate consistently superior medical cannabis for our products.”

About Dixie Elixirs & Edibles

As Colorado’s premier Medical Marijuana infused products company, Dixie Elixirs & Edibles™, based in Denver, CO has been providing alternative medicated relief for patients in Colorado since 2009. Dedicated to providing the strength, taste and discretion required by medical marijuana patients, Dixie Elixirs & Edibles provides a complete line of smoke-free medical marijuana products including Dixie Elixirs™ medicated beverages, Dixie Edibles™ infused edibles, Dixie Scrips™ cannabis and herb supplement capsules, Dixie Botanicals™ all-natural transdermal topicals, Dixie Dew Drops™ concentrated tinctures, and Dixie Tonics™ medicated energy boosts. Dixie Elixirs & Edibles products are sold through licensed medical marijuana centers in Colorado in compliance with CO HB 1284.

www.dixieelixirs.com
www.facebook.com/dixieelixirs

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.

Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:
Equiti-trend Advisors, LLC
Toll Free: 800-953-3350

admin1@equititrend.com
www.equititrend.com

CONTACT
Tripp Keber, Dixie Elixirs (303) 945-2049, tkeber@leftbankllc.com

SOURCE Medical Marijuana, Inc

Source: PR Newswire (May 10, 2012 – 8:30 AM EDT)

SEATTLE, May 7, 2012 (GLOBE NEWSWIRE) — Plandai Biotechnology, Inc., a producer of highly bioavailable plant extracts, today filed a Form 8-K with the Securities and Exchange Commission announcing that it has executed the final loan documents with the Land and Agriculture Bank of South Africa. The total amount of the loan is 100 million Rand (US $13 million).

Plandai Chairman and Chief Executive Officer, Roger Duffield, commented, “Closing this loan is a significant milestone for Plandai because it provides us with the capital necessary to move immediately into production of our highly bioavailable Green Tea extract without causing any dilution to our shareholders. Since first receiving approval for the loan from the Land Bank in December 2011, we have worked diligently to gather the necessary legal documents and ensure compliance with the loan terms. Gratefully, that patience and effort has finally paid off.”

In discussing the use of proceeds from the loan, Mr. Duffield added, “We are working on a very short time table in order to reach our goal of having product market ready by early 2013. We have already contracted with our USA engineering partner, CRS Technologies Inc. Delaware, to commence the manufacture of our first hydrodynamic processing and extraction system, in order that we can begin the first commercial, bioavailable Green Tea catechin extract production by the end of the year. At the same time, we have begun work on our Senteeko tea estate to make sure there is suitable and adequate green tea crop available in the last quarter 2012. True to the purpose of the Land Bank loan, we will be employing many of the local Shamile community members to help in the farming and extraction process.”

The Land and Agriculture Bank of South Africa (http://www.landbank.co.za/) is a specialist agricultural bank guided by a government mandate to provide financial services to the commercial farming sector and to agri-business and to facilitate access to finance by new entrants to agriculture from historically disadvantaged backgrounds.

About Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. Its principle holdings consist of land, farms and infrastructure in South Africa. Web site: http://www.plandaibiotech.com/

Safe Harbor Statement

The information provided may contain forward-looking statements and involve risks and uncertainties. Results, events and performances could vary from those contemplated. These statements involve risks and uncertainties which may cause actual results, expressed or implied, to differ from predicted outcomes. Risks and uncertainties include product demand, market competition, and Plandai’s ability to meet current or future plans. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Plandai is not obliged to publicly release revisions to any forward-looking statement, to reflect events or circumstances afterward, or to disclose unanticipated occurrences, except as required under applicable laws.

CONTACT: Tel: (425) 466-0212
Email: info@Plandaibiotech.com

Source: Globe Newswire (May 7, 2012 – 9:35 AM EDT)

SALT LAKE CITY, UT — (Marketwire) — 05/07/12 — Green Endeavors, Inc. (OTCQB: GRNE) (PINKSHEETS: GRNE), a majority owned subsidiary of Nexia Holdings, Inc. (PINKSHEETS: NXHD) is proud to announce that Landis Lifestyle Salons has been recognized as Best of State-Utah for Hair/Beauty Salons for the second year in a row. The salons will be recognized at the Best of State Awards Gala to be held at the Salt Palace Convention Center on May 22, 2012 in Salt Lake City, Utah. For more information on the award, go to http://bestofstate.org/winner2012_merchandising.html.

Landis Lifestyle Salons was also recognized by QSaltLake, a local bi-weekly newspaper in their 2012 Fabby Awards as the best hair salon with the following statement:

“Best Hair Salon-Landis Lifestyle Salons — Enjoy the pampering services at Landis Lifestyle Salons in Sugarhouse and the Marmalade districts of Salt Lake City. Colors, cuts, perms, and other services are just the proverbial tip of the iceberg with this fabulous salon.”

Richard Surber, the CEO of GRNE, observed, “This repeated recognition of the high standards that our salons have been utilizing in customer service outreach into the community and environmental awareness is a result of the daily goals of our staff and management in each of these areas. Landis Salons intends to maintain the high standards that have led to this award being given us for two years in a row. We plan to expand the number of salons we operate and work to provide the highest level of quality service in each of our salons.”

About Green Endeavors, Inc.

Green Endeavors, Inc. (OTCQB: GRNE) (PINKSHEETS: GRNE), headquartered in Salt Lake City, Utah, is a holding company with operations in health & beauty. GRNE’s wholly owned subsidiaries, Landis Salons, Inc., Landis Salons II, Inc., and Landis Experience Center, LLC http://www.landissalons.com, operate hair salons built around the world-class AVEDA™ product line. For more information, visit http://www.green-endeavors.com. The numbers are audited/reviewed by an independent accountant. GRNE strongly encourages the public to read the above information in conjunction with its filings and disclosures filed in 2010 and 2011. GRNE’s disclosures can be viewed at www.sec.gov and www.otcmarkets.com. Investors should not invest more than they can afford to lose in penny stocks.

Richard Surber
President
Green Endeavors, Inc.
801-575-8073 x 106
Email Contact

Source: Marketwire (May 7, 2012 – 9:00 AM EDT)